Despite a soft first quarter 2015 for the 13 IP licensing company stocks that comprise the PIPX IP Stock Index, versus the S&P 500, individual
Category: Research
Patent quality — Is a “shared responsibility”, says IBM; it does not represent invention quality or IP value
There is a great deal of agreement that patent quality is lacking, but surprisingly little about how to define and achieve it. Patent quality is
Patent ‘Quality Summit’ will be open to the public, March 25-26
The goal of the USPTO gathering is to promote discussion of ways to improve patent quality. The first Patent Quality Summit will take place at
Rohrabacher to Congress: “Don’t let the ‘Innovation Act’ be a part of our legacy”
Not everyone agrees that another round of patent reform is necessary at this time. Doubters believe that the Innovation Act, H.R. 9 in its current form, will
Life360: “It is a huge stretch to say we are infringing”
The comment that follows is from Life360 CEO Chris Hulls in response to the 2/9/15 IP CloseUp post, “Family App Developer Says it’s the Victim
Family App Developer Says it’s the Victim of a Patent “Troll” — Research Indicates Otherwise
When it comes to invention rights (patents) it is often difficult to determine who is a victim and who is merely promoting its agenda. Life360,
US Tech Cos are Bulking-up On Software and Methods Patents
More than half of Google and Microsoft’s 2014 US patent grants were in methods-related classes. IBM and Apple also were active filers in these areas.
A Few IP Stocks Shined in 2014; Most Declined, Some Significantly
Size helped in 2014 when it came to public IP licensing company stock performance, but it did not assure success. As a group, the twelve
Nine Companies in IP CloseUp 30 Index Fall Below $1/share
More than one-third of the IP CloseUp® 30 public patent licensing companies (or PIPCOs) are currently selling for less than or about $1 per share —
InterDigital and Tessera Soar in (for now) a Strong 4Q for Stocks
The stock market continues to defy expectations. Even more surprising, a few PIPCOs have dramatically outperformed it. Smaller cap patent stocks have not fared so
$3.3B Patent Royalty Deal, the Largest Ever, is Windfall for Charity
The rights to an expensive drug treatment owned by the Cystic Fibrosis Foundation has helped it to reap a financial windfall but is not without
Some Licensing Companies will Likely Benefit from Higher Patent Hurdles
As businesses adjust to new judicial and legislative requirements public patent licensing companies will have to work harder and think smarter to compete against the
